David Bardsley

Cresset BioMolecular Discovery Ltd. provides software for computational chemistry and offers contract research services to various industries including pharmaceutical, biotechnology, flavor, fragrance, and agrochemical. The company is based in Litlington, UK and was founded in 2002 by Mark Mackey and Tim Cheeseright. The British company's software is used by computational, medicinal, and synthetic chemists for ligand-based and structure-based design to discover new small molecules. The CEO is Robert Scoffin.

Cresset BioMolecular Discovery Ltd. provides software for computational chemistry and offers contract research services to various industries including pharmaceutical, biotechnology, flavor, fragrance, and agrochemical. The company is based in Litlington, UK and was founded in 2002 by Mark Mackey and Tim Cheeseright. The British company's software is used by computational, medicinal, and synthetic chemists for ligand-based and structure-based design to discover new small molecules. The CEO is Robert Scoffin.

Cresset BioMolecular Discovery Ltd. provides software for computational chemistry and offers contract research services to various industries including pharmaceutical, biotechnology, flavor, fragrance, and agrochemical. The company is based in Litlington, UK and was founded in 2002 by Mark Mackey and Tim Cheeseright. The British company's software is used by computational, medicinal, and synthetic chemists for ligand-based and structure-based design to discover new small molecules. The CEO is Robert Scoffin.

Cresset BioMolecular Discovery Ltd. provides software for computational chemistry and offers contract research services to various industries including pharmaceutical, biotechnology, flavor, fragrance, and agrochemical. The company is based in Litlington, UK and was founded in 2002 by Mark Mackey and Tim Cheeseright. The British company's software is used by computational, medicinal, and synthetic chemists for ligand-based and structure-based design to discover new small molecules. The CEO is Robert Scoffin.

Cresset BioMolecular Discovery Ltd. provides software for computational chemistry and offers contract research services to various industries including pharmaceutical, biotechnology, flavor, fragrance, and agrochemical. The company is based in Litlington, UK and was founded in 2002 by Mark Mackey and Tim Cheeseright. The British company's software is used by computational, medicinal, and synthetic chemists for ligand-based and structure-based design to discover new small molecules. The CEO is Robert Scoffin.